Israel Wojnowich
Family Medicine · St Petersburg, FLNPI 1508165390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 245 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$972
- Boehringer Ingelheim$674
- AstraZeneca$632
- Novo Nordisk$618
- Pfizer$255
- Exact Sciences$205
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,70699%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $972 |
| Boehringer Ingelheim | 29 | $674 |
| AstraZeneca | 39 | $632 |
| Novo Nordisk | 34 | $618 |
| Pfizer | 16 | $255 |
| Exact Sciences | 10 | $205 |
| GSK | 10 | $203 |
| Jazz Pharmaceuticals Inc. | 6 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Novartis | 4 | $114 |
| Abbott | 5 | $108 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $94 |
| Amarin Pharma, Inc. | 3 | $58 |
| Currax Pharmaceuticals LLC | 3 | $53 |
| Bayer | 2 | $52 |
| Astellas Pharma US Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $34 |
| Gilead | 1 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Antares Pharma, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Merck | 1 | $14 |
How this compares
$4,731 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $14,226 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $877 |
| Gabapentin | 46 | $472 |
| Levothyroxine Sodium | 47 | $400 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 14 | $219 |
| Atorvastatin Calcium | 31 | $171 |
| Aripiprazole | 14 | $170 |
| Eszopiclone | 27 | $163 |
| Bupropion Hcl | 11 | $133 |
| Lisinopril | 35 | $128 |
| Pantoprazole Sodium | 16 | $103 |
| Hydrochlorothiazide | 13 | $90 |
| Alprazolam | 28 | $90 |
| ClopidogrelClopidogrel Bisulfate | 12 | $88 |
| Metoprolol Tartrate | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other family medicine in St Petersburg
- Edward BraunSt Petersburg$364K
- Robert WallaceSt Petersburg$144K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.